CGONCG Oncology, Inc.
$61.68+47% 1Y
$61.68
$37.3752 weeks$80.66
Is it growing?
Good
2 good, 1 without dataGrowing: revenue growing +1030% year on year and operating margin widening (+525076.9 points).
Revenue trend+1030% in a year
Trailing-twelve-month revenue vs a year earlier, from the company's own filings.
Margin direction+525076.9 points operating
Trailing-twelve-month operating margin, -4691.0% now against -529767.9% a year earlier.
All from SEC EDGAR, as of Jun 30, 2026.
Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.
Is CGON growing?
- Years of annual history on file
- 3
Years of annual history on file · FY2023 to FY2025, as filed
Details›
- Revenue FY2023
- $204K
- Revenue FY2024
- $1.1M
- Revenue FY2025
- $4.0M
Annual income statements as filed with the SEC.
On our screens:Most shorted stocks
Biotechnology
The closest names by size in the same industry